Medical/Pharmaceuticals
CROMSOURCE Announces a Significant Milestone in Digital Management of Its Projects in Cooperation with Techorizon
VERONA, Italy, March 3, 2020 /PRNewswire/ -- CROMSOURCE announced today the achievement of a significant milestone in the digital management of clinical research projects for their clients. InFebruary 2020 CROMSOURCE initiated the 1000th trial to be managed within the advanced TheClinical digital...
2020-03-03 20:00
2678
CEO Richard Twomey Leaves Molnlycke
GOTHENBURG, Sweden, March 3, 2020 /PRNewswire/ -- Richard Twomey, President and CEO of Molnlycke, will after six years leave the organisation. "Richard has with his deep knowledge and experience within the medical technology industry developed Molnlycke into an even stronger company in its field...
2020-03-03 15:30
1499
Bactiguard Completes Acquisition of Vigilenz
STOCKHOLM, March 2, 2020 /PRNewswire/ -- Bactiguard Holding AB (publ) ("Bactiguard") has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on4 February 2020. All conditions precedent have been fulfilled and the first part...
2020-03-02 22:06
9012
ConvaTec sharpens focus on Asia Pacific and emerging markets
SINGAPORE, March 2, 2020 /PRNewswire/ -- ConvaTec Group Plc is putting the Asia Pacific region, along with Latin America, The Middle East and Africa, at the forefront of its new operating model by establishing a fully integrated business unit called the Global Emerging Markets (GEM), according to...
2020-03-02 18:06
9802
Yuyu Pharma, Laying the foundation for establishing a global-level compliance system with one of Korea's top law firms
SEOUL, South Korea, March 2, 2020 /PRNewswire/ -- Yuyu Pharma (COO Robert Wonsang Yu, KRX 000220) announced today a review of its compliance policies and procedures with the support of the law firm, Kim & Chang. The Kim & Chang project team, consisting of 6 lawyers and 1 expert advisor, implement...
2020-03-02 17:00
1330
ERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
Approval is for ERBITUX® in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHN Pivotal Phase III study shows significant improvements with ERBITUX® in combination with platinum-based therapy with fluorouracil in response rate, disease progression ...
2020-03-02 15:02
5185
Sihuan Pharmaceutical Announces Clinical Research of Favipiravir, Co-Developed with the Academy of Military Medical Sciences of the People's Liberation Army, Has Commenced
HONG KONG, March 2, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that the clinical research of Favipiravir tablet, which was co-developed by the Group and t...
2020-03-02 14:15
7723
Luminex Corporation Submits VERIGENE(R) II Respiratory Flex Assay for FDA Clearance
AUSTIN, Texas, March 2, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that the company has submitted an application to the U.S. Food and Drug Administration (FDA) for 510(k) clearance of the VERIGENE® II RespiratoryFlex Assay, the second VERIGENE II assay to be submitted...
2020-03-02 10:00
6045
Researchers Worldwide Are Using Berkeley Lights' Beacon Platform To Combat COVID-19
Berkeley Lights' proprietary technology, the Beacon® optofluidic platform, is currently used by researchers across three continents—the U.S.,China, and Australia—to help them find solutions for the Coronavirus EMERYVILLE, Calif., Feb. 29, 2020 /PRNewswire/ -- Berkeley Lights, Inc., a leader in c...
2020-02-29 01:00
3791
Wuhan's war on COVID-19: How China mobilizes the whole country to contain the virus
BEIJING, Feb. 28, 2020 /PRNewswire/ -- CGTN recently looked back on China's efforts to fight the ongoing new coronavirus outbreak in a recent report and released an original video. A health crisis struck China on the cusp of the new year. Wuhan, a metropolis of 11 million residents in central...
2020-02-28 20:18
4619
Ping An Launches COVID-19 Smart Image-Reading System to Help Control the Epidemic
HONG KONG and SHANGHAI, Feb. 28, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 02318; SSE: 601318) announced that the Corona Virus Disease 2019 (COVID-19) smart image-reading system was launched on 19 February. It wa...
2020-02-28 19:40
10468
LOTTE Vietnam Shopping Joint Stock Company donates medical masks for the Hospital for Tropical Diseases
HO CHI MINH CITY, Vietnam, Feb. 28, 2020 /PRNewswire/ -- LOTTE Vietnam Shopping Joint Stock Company donated 30,000 medical masks of Choice L brand to the Hospital for Tropical Diseases inHo Chi Minh City to help reverse the Covid-19 epidemic. Given the complicated situation of Covid-19, the dema...
2020-02-28 16:27
4148
JLK Inspection has announced signing of a partnership with the National TB Center (NTC) and the Clinton Health Access Initiatives (CHAI) in Lao PDR to conduct a tuberculosis screening project
SEOUL, South Korea, Feb. 28, 2020 /PRNewswire/ -- JLK Inspection Inc.
2020-02-28 14:51
1946
DERMALOG Fever Detection in Operation at Hanover Exhibition Grounds
The spread of coronavirus also affects the event industry. Congresses and trade fairs are postponed or even canceled worldwide for fear of a pandemic. Event organizer UKi Media & Events is using innovative technology from DERMALOG at its present trade fair inHanover to protect its visitors. HAMB...
2020-02-27 21:52
1870
Tessa Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to its CD30 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory CD30-positive Classical Hodgkin Lymphoma
SINGAPORE, Feb. 27, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced that the Company's investigational CD30-directed autologous chimeric antigen receptor T cell (CD30 CAR-T) therapy has been gran...
2020-02-27 20:00
2213
European Medicines Agency accepts submission of GSK's Marketing Authorisation Application for Zejula (niraparib) in first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer
- Submission based on data from the Phase III PRIMA clinical study that demonstrated clinically meaningful outcomes of niraparib maintenance treatment in the first-line setting regardless of biomarker status LONDON, Feb. 27, 2020 /PRNewswire/ -- GlaxoSmithKline plc announced that the European M...
2020-02-27 17:00
1397
Country Garden Delivered 100,000 Protective Suits Directly from Sydney to Wuhan to Support Healthcare Workers
FOSHAN, China, Feb. 27, 2020 /PRNewswire/ -- On February 24, 2020, nearly 100,000 protective suits purchased by Country Garden Holdings (HK:2007) through the Guoqiang Foundation were delivered directly fromSydney, Australia to Wuhan via a chartered airplane. Along with supplies and equipment d...
2020-02-27 11:24
9334
Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
HANGZHOU and SHAOXING, China, Feb. 27, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today the advancement in Novel Coronavirus Pneumonia clinical trial of oral Ganovo® and Ritonavir combination therapy, led by Dr. Hongyi CHEN, the director of the Ninth Hospital ofNanchang...
2020-02-27 08:00
3870
New VITROS® XT 3400 Chemistry System from Ortho Clinical Diagnostics Enhances Its VITROS® XT Solutions, Offering Labs Faster, More Accurate Results and Trusted System Reliability to Ensure Better Patient Outcomes
RARITAN, N.J., Feb. 27, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the launch and availability of the VITROS® XT 3400 Chemistry System, which completes th...
2020-02-27 01:40
2213
Global Pharmaceutical Contract Manufacturing Organization Market to Reach $102.14 Billion by 2024
Advancements in flexible manufacturing technology to help address new demand in personalized medicine, finds Frost & Sullivan SANTA CLARA, California, Feb. 27, 2020 /PRNewswire/ -- Contract manufacturing organizations (CMOs) are currently transitioning from transactional relationships to strateg...
2020-02-27 01:28
1493
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 312 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 296 media titles]
2024-11-15 15:25
Most Read
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
2024-11-15 15:25
8700
How "small apples" march into "big industry" in Yan'an
2024-11-15 17:39
5793
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5179
